Home Online Features Linnaeus Therapeutics Awarded Its Fourth Competitive SBIR Award by the National Cancer Institute Bringing Total SBIR Funding to $8.3 Million
Linnaeus Therapeutics Awarded Its Fourth Competitive SBIR Award by the National Cancer Institute Bringing Total SBIR Funding to $8.3 Million
Hand-out
Press Releases
Linnaeus Therapeutics, Inc.  
March 26, 2025

Linnaeus Therapeutics Awarded Its Fourth Competitive SBIR Award by the National Cancer Institute Bringing Total SBIR Funding to $8.3 Million

$2,000,000 Direct-to-Phase 2 Award Funds Study of LNS8801 in the Treatment of Melanoma

logo salamanca press

Salamanca Press

email salamanca press
Local & Social